Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Revealing the Synergistic Potential of Mosunetuzumab Plus Polatuzumab Vedotin through CD20 Upregulation

Natsumi Kawasaki, Sei Shu, Xiaoxiao Liu, Shigeki Yoshiura

Blood (2024) 144 (Supplement 1): 4171.

https://doi.org/10.1182/blood-2024-198107

Published: 2024

Journal Articles

Infiltration of Innate Immune Cells into Tumors By Polatuzumab Vedotin Treatment Contributes to Its Antitumor Effect in Xenograft and Syngeneic Mouse Models

Mayu Tomita, Natsumi Kawasaki, Keigo Yorozu, Mitsue Kurasawa, Bansho Masutani, Nicolas Sax, Sei Shu, Yoriko Yamashita-Kashima, Shigeki Yoshiura

Blood (2024) 144 (Supplement 1): 4166.

https://doi.org/10.1182/blood-2024-198060

Published: 2024

Journal Articles

Retreatment with Polatuzumab Vedotin in Combination with Rituximab Increases Antitumor Activity Against Polatuzumab Vedotin-Resistant DLBCL Cells

Natsumi Kawasaki, Mayu Tomita, Yoriko Yamashita-Kashima, Yasushi Yoshimura, Shigeki Yoshiura

Blood (2022) 140 (Supplement 1): 6006–6007.

https://doi.org/10.1182/blood-2022-157667

Published: 2022

Journal Articles

Obinutuzumab-Retreatment in Combination with Bendamustine Is Effective for Obinutuzumab Resistant Models in Vitro and In Vivo

Yoriko Yamashita-Kashima, PhD, Natsumi Kawasaki, PhD, Keigo Yorozu, DVM, PhD, Shigeki Yoshiura, PhD, Takaaki Fujimura, MS, Mitsue Kurasawa, MS, Naoki Harada, PhD, Yasushi Yoshimura, MS

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-136877

Published: 2020